Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Despite Labcorp Holdings’ underperformance relative to its industry peers, Wall Street analysts remain strongly optimistic ...

Labcorp Holdings recently reported better-than-expected Q3 2025 adjusted EPS of $4.18 but cut its contract research unit’s annual and full-year revenue growth forecasts due to a prolonged funding ...

The company says it can turn profits without its customers facing the usual out-of-pocket costs or high premiums. Economists ...

In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...

The "Pharmaceutical Safety Assessment Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The pharmaceutical safety assessment market has demonstrated significant growth, ...

Precision Psychiatry Market is projected to reach US$ 4.2 Bn by 2035, driven by rapid integration of AI and ML in psychiatric ...

In their ongoing commitment to support clinicians at the point of care, EBSCO Clinical Decisions and Micromedex today announced that Dyna AI for DynaMedex® will soon deliver expanded drug content and ...

The 5 testing & diagnostics services stocks we track reported a very strong Q3. As a group, revenues beat analysts’ consensus ...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

Learn how to identify RSV symptoms in adults, how to know if an RSV infection has become serious, how to avoid RSV, and ...

During the year, the industry saw continued consolidation, the end of a key advisory body, the rise in DTC testing and advanced diagnostics, and another stab at PAMA reform.